Steven H. Holtzman

2008 - Infinity Pharmaceuticals

In 2008, Steven H. Holtzman earned a total compensation of $1.4M as Executive Chair at Infinity Pharmaceuticals, a 61% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$288,000
Option Awards$592,400
Salary$480,000
Other$7,332
Total$1,367,732

Holtzman received $592.4K in option awards, accounting for 43% of the total pay in 2008.

Holtzman also received $288K in non-equity incentive plan, $480K in salary and $7.3K in other compensation.

Rankings

In 2008, Steven H. Holtzman's compensation ranked 3,455th out of 9,135 executives tracked by ExecPay. In other words, Holtzman earned more than 62.2% of executives.

ClassificationRankingPercentile
All
3,455
out of 9,135
62nd
Division
Manufacturing
1,236
out of 3,436
64th
Major group
Chemicals And Allied Products
231
out of 815
72nd
Industry group
Drugs
130
out of 597
78th
Industry
Pharmaceutical Preparations
96
out of 408
77th
Source: SEC filing on April 11, 2011.

Holtzman's colleagues

We found three more compensation records of executives who worked with Steven H. Holtzman at Infinity Pharmaceuticals in 2008.

2008

Adelene Perkins

Infinity Pharmaceuticals

Chief Executive Officer

2008

Julian Adams

Infinity Pharmaceuticals

President of R&D

2008

Vito Palombella

Infinity Pharmaceuticals

Chief Scientific Officer

You may also like